PatentVest is the first technology commercialization intelligence platform to assist technologists, advisors, venture capitalists, and established companies to optimize technology commercialization.
Rational Design Process For New Companies
Innovation in a box. Our process transforms IP and innovation from a complex legal process into a manageable, measurable business process.
Deeply understand all the players in the defined technology space and how they relate to your company’s technology, IP, and new inventions.
Gain a clear understanding of what your company’s competitive advantage could be, and clearly articulate a go-forward strategy.
Develop a business, IP, and innovation strategy that enables your company to create a new technology category and become the leader of that category.
Re-evaluate continuously, which keeps your company a category leader or enables you to pivot to a new strategy based on changing circumstances.
Companies we have taken through this process that began as ideas and became sustainable public companies.
Provention Bio, Inc. (Nasdaq: PRVB) is a clinical-stage biopharmaceutical company leveraging a transformational drug development strategy focused on the prevention or interception of immune-mediated disease.
Cue Biopharma (Nasdaq: CUE), is a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases.
Traditional patent data providers just provide data. We provide strategic guidance by turning data into answers.
For over 18 years, we have developed and perfected proprietary tools, software, and processes that enable our teams to rapidly scan the global body of knowledge, mining innovation data unavailable anywhere else.
In cooperation with your company, our teams use the tools, software, and processes that we have developed to deeply investigate the business and IP landscape, identifying companies, technologies, and patents directly relevant to you.
We then take this complex information and provide actionable answers and actionable steps, enabling your company to develop a coherent business, IP, and R&D strategy that is unified and rational.
A paint by numbers approach
Our reports provide actionable answers that enable our clients to develop a business, IP, and R&D strategy that is unified, rational, and coherent.
PRIOR ART PLUS REPORT
Should we file for a patent?
The average cost to file a patent in the US and WIPO is $56K. Our Prior Art Plus Report enables our clients with new inventions or provisional patents to quickly determine if they should file for a patent or mend their patent application.